GUY SEABROOK, PH.D.
As Head of External Innovation for Neuroscience, Guy Seabrook, Ph.D. creates and implements the external innovation plan to deliver the Neuroscience Therapeutic Area Research & Development strategy. Guy and his team work to identify the best opportunities for value-generating collaborations and develop an industry-leading portfolio of investment opportunities, which involves the cultivation of a strong scientific network of experts in the global innovation community.
He has over 30 years of experience in drug discovery research, which includes preclinical research on marketed products and candidates in clinical development. Formerly, Guy was part of Eli Lilly’s Global External Research & Development (GER&D) organization where he led the GER&D team for the Lilly Bio-Medicines Business Unit, and also at Merck & Co, Inc., where he was the Head of the West Point Department of Alzheimer's Disease Research.
He graduated with a Ph.D. in Zoology from the University of Nottingham in 1987 and completed his postdoctoral research at the University of Miami School of Medicine.